Log In
Print
BCIQ
Print
Print this Print this
 

HSC835

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionLFU835-expanded umbilical cord blood hematopoietic stem cells for transplantation
Molecular Target
Mechanism of ActionCell therapy
Therapeutic ModalityCell therapy
Latest Stage of DevelopmentPhase II
Standard IndicationHematologic malignancies
Indication DetailsHematologic malignancies
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today